Article Information
PubMed
Published By
History
- Received May 22, 2023
- Revision received December 13, 2023
- Accepted December 19, 2023
- Published online February 13, 2024.
Copyright & Usage
Copyright © 2024 Keomanivong et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Cameron Keomanivong1,*,
- Josephine Schamp2,*,
- Ervina Tabakovic1,
- Ramasamy Thangavel3,
- Georgina Aldridge3,
- Andrew A. Pieper4 and
- Nandakumar S. Narayanan3
- 1Carver College of Medicine, University of Iowa, Iowa City 52245, Iowa
- 2York University, York 68467, Nebraska
- 3Department of Neurology, University of Iowa, Iowa City 52245, Iowa
- 4Brain Health Medicines Center, Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland 44106, Ohio; Department of Psychiatry, Case Western Reserve University, Cleveland 44106, Ohio; Geriatric Research Education and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center, Cleveland 44106, Ohio; Institute for Transformative Molecular Medicine, School of Medicine, Case Western Reserve University, Cleveland 44106, Ohio; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland 44106, Ohio; Department of Neuroscience, School of Medicine, Case Western Reserve University, Cleveland 44106, Ohio; Translational Therapeutics Core, Cleveland Alzheimer’s Disease Research Center, Cleveland, Ohio
- Correspondence should be addressed to Nandakumar S. Narayanan at nandakumar-narayanan{at}uiowa.edu.
Author contributions
Author contributions: C.K., J.S., G.A., A.A.P., and N.S.N. designed research; C.K., J.S., R.T., and G.A. performed research; C.K., J.S., E.T., and N.S.N. analyzed data; C.K., G.A., A.A.P., and N.S.N. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by Titan Neurological Fund.
↵*C.K. and J.S. contributed equally to this work.
Funding
Titan Neurological Fund
Article usage
In this issue
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits
